A prevalência global de OVR em 2015, independentemente do tipo, foi de 0.77% entre pessoas com idade entre 30-89 anos em uma metanálise.[2]Song P, Xu Y, Zha M, et al. Global epidemiology of retinal vein occlusion: a systematic review and meta-analysis of prevalence, incidence, and risk factors. J Glob Health. 2019 Jun;9(1):010427.
https://www.doi.org/10.7189/jogh.09.010427
http://www.ncbi.nlm.nih.gov/pubmed/31131101?tool=bestpractice.com
A prevalência global de oclusão da veia retiniana central (OVRC) foi de 0.13%, enquanto a prevalência de oclusão de ramo da veia retiniana (ORVR) foi de 0.64%.[2]Song P, Xu Y, Zha M, et al. Global epidemiology of retinal vein occlusion: a systematic review and meta-analysis of prevalence, incidence, and risk factors. J Glob Health. 2019 Jun;9(1):010427.
https://www.doi.org/10.7189/jogh.09.010427
http://www.ncbi.nlm.nih.gov/pubmed/31131101?tool=bestpractice.com
A incidência de OVR aumenta com a idade.[2]Song P, Xu Y, Zha M, et al. Global epidemiology of retinal vein occlusion: a systematic review and meta-analysis of prevalence, incidence, and risk factors. J Glob Health. 2019 Jun;9(1):010427.
https://www.doi.org/10.7189/jogh.09.010427
http://www.ncbi.nlm.nih.gov/pubmed/31131101?tool=bestpractice.com
[3]The Royal College of Opthalmologists. Retinal vein occlusion guidelines. Feb 2022 [internet publication].
https://www.rcophth.ac.uk/resources-listing/retinal-vein-occlusion-rvo-guidelines
A OVRC e a ORVR ocorrem principalmente em indivíduos com >65 anos de idade e são relativamente incomuns em indivíduos com <40 anos.[4]Flaxel CJ, Adelman RA, Bailey ST, et al. Retinal vein occlusions preferred practice pattern®. Ophthalmology. 2020 Feb;127(2):P288-320.
https://www.aaojournal.org/article/S0161-6420(19)32096-2/fulltext
http://www.ncbi.nlm.nih.gov/pubmed/31757503?tool=bestpractice.com
[5]Mitchell P, Smith W, Chang A. Prevalence and associations of retinal vein occlusion in Australia. The Blue Mountains Eye Study. Arch Ophthalmol. 1996 Oct;114(10):1243-7.
http://www.ncbi.nlm.nih.gov/pubmed/8859084?tool=bestpractice.com
[6]Klein R, Klein BE, Moss SE, et al. The epidemiology of retinal vein occlusion: the Beaver Dam Eye Study. Trans Am Ophthalmol Soc. 2000;98:133-41.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1298220/pdf/taos00001-0142.pdf
http://www.ncbi.nlm.nih.gov/pubmed/11190017?tool=bestpractice.com
[7]Hayreh SS, Zimmerman MB, Podhajsky P. Incidence of various types of retinal vein occlusion and their recurrence and demographic characteristics. Am J Ophthalmol. 1994 Apr 15;117(4):429-41.
http://www.ncbi.nlm.nih.gov/pubmed/8154523?tool=bestpractice.com
Em um estudo, 71% dos pacientes com OVRC e 77% dos pacientes com ORVR tinham idade ≥65 anos.[6]Klein R, Klein BE, Moss SE, et al. The epidemiology of retinal vein occlusion: the Beaver Dam Eye Study. Trans Am Ophthalmol Soc. 2000;98:133-41.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1298220/pdf/taos00001-0142.pdf
http://www.ncbi.nlm.nih.gov/pubmed/11190017?tool=bestpractice.com
A incidência é igual nos homens e nas mulheres, e nenhuma diferença racial na prevalência foi relatada.[1]Romano F, Lamanna F, Gabrielle PH, et al. Update on retinal vein occlusion. Asia Pac J Ophthalmol (Phila). 2023 Mar-Apr;12(2):196-210.
https://journals.lww.com/apjoo/fulltext/2023/03000/update_on_retinal_vein_occlusion.7.aspx
http://www.ncbi.nlm.nih.gov/pubmed/36912792?tool=bestpractice.com
[2]Song P, Xu Y, Zha M, et al. Global epidemiology of retinal vein occlusion: a systematic review and meta-analysis of prevalence, incidence, and risk factors. J Glob Health. 2019 Jun;9(1):010427.
https://www.doi.org/10.7189/jogh.09.010427
http://www.ncbi.nlm.nih.gov/pubmed/31131101?tool=bestpractice.com
[3]The Royal College of Opthalmologists. Retinal vein occlusion guidelines. Feb 2022 [internet publication].
https://www.rcophth.ac.uk/resources-listing/retinal-vein-occlusion-rvo-guidelines
[5]Mitchell P, Smith W, Chang A. Prevalence and associations of retinal vein occlusion in Australia. The Blue Mountains Eye Study. Arch Ophthalmol. 1996 Oct;114(10):1243-7.
http://www.ncbi.nlm.nih.gov/pubmed/8859084?tool=bestpractice.com
[6]Klein R, Klein BE, Moss SE, et al. The epidemiology of retinal vein occlusion: the Beaver Dam Eye Study. Trans Am Ophthalmol Soc. 2000;98:133-41.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1298220/pdf/taos00001-0142.pdf
http://www.ncbi.nlm.nih.gov/pubmed/11190017?tool=bestpractice.com
O Beaver Dam Study relatou que a taxa de incidência de OVRC é de 0.002/pessoa em um período de 5 anos e 0.005 por pessoa em um período de 15 anos.[6]Klein R, Klein BE, Moss SE, et al. The epidemiology of retinal vein occlusion: the Beaver Dam Eye Study. Trans Am Ophthalmol Soc. 2000;98:133-41.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1298220/pdf/taos00001-0142.pdf
http://www.ncbi.nlm.nih.gov/pubmed/11190017?tool=bestpractice.com
[8]Klein R, Moss SE, Meuer SM, et al. The 15-year cumulative incidence of retinal vein occlusion: The Beaver Dam Eye Study. Arch Ophthalmol. 2008 Apr;126(4):513-8.
http://www.ncbi.nlm.nih.gov/pubmed/18413521?tool=bestpractice.com
A taxa de incidência de ORVR foi relatada como sendo de 0.006 por pessoa em um período de 5 anos e 0.018 por pessoa em um período de 15 anos.[6]Klein R, Klein BE, Moss SE, et al. The epidemiology of retinal vein occlusion: the Beaver Dam Eye Study. Trans Am Ophthalmol Soc. 2000;98:133-41.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1298220/pdf/taos00001-0142.pdf
http://www.ncbi.nlm.nih.gov/pubmed/11190017?tool=bestpractice.com
[8]Klein R, Moss SE, Meuer SM, et al. The 15-year cumulative incidence of retinal vein occlusion: The Beaver Dam Eye Study. Arch Ophthalmol. 2008 Apr;126(4):513-8.
http://www.ncbi.nlm.nih.gov/pubmed/18413521?tool=bestpractice.com
Dos pacientes com oclusão da veia retiniana central em um olho, 1% por ano desenvolverão uma OVR de qualquer tipo no olho contralateral e 7% desenvolverão outra OVRC no olho contralateral em um período de 5 anos.[7]Hayreh SS, Zimmerman MB, Podhajsky P. Incidence of various types of retinal vein occlusion and their recurrence and demographic characteristics. Am J Ophthalmol. 1994 Apr 15;117(4):429-41.
http://www.ncbi.nlm.nih.gov/pubmed/8154523?tool=bestpractice.com
[9]The Central Vein Occlusion Study Group. Natural history and clinical management of central retinal vein occlusion. Arch Ophthalmol. 1997 Apr;115(4):486-91. [Erratum in: Arch Ophthalmol 1997 Oct;115(10):1275.]
http://www.ncbi.nlm.nih.gov/pubmed/9109757?tool=bestpractice.com
[10]Hayreh SS. Central retinal vein occlusion. Ophthalmol Clin North Am. 1998 Dec 1;11(4):559-90.
http://www.ophthalmology.theclinics.com/article/S0896-1549(05)70079-1/abstract
Similarmente, 10% dos pacientes com ORVR em um olho podem apresentar uma oclusão da veia retiniana (OVR) de qualquer tipo em um período de 3 anos.
A OVRC resulta em comprometimento visual com mais frequência que a ORVR, sendo o edema macular a principal causa.[3]The Royal College of Opthalmologists. Retinal vein occlusion guidelines. Feb 2022 [internet publication].
https://www.rcophth.ac.uk/resources-listing/retinal-vein-occlusion-rvo-guidelines